Avycaz (ceftazidime/avibactam) Patient Assistance Program

Don’t let the high cost of brand ceftazidime-avibactam disrupt your resistant gram-negative infection treatment. We help eligible patients access Avycaz (ceftazidime + avibactam IV) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.

Key ​Takeaways:

What is Avycaz Prescription Assistance Program?

The Avycaz Patient Assistance Program is a manufacturer-sponsored initiative that helps eligible patients access Avycaz for resistant gram-negative infections at little or no cost when meeting income, insurance, and clinical criteria. The program is free to apply for, but involves detailed applications, infectious disease coordination, culture/sensitivity documentation, and ongoing renewal.

At AffordMyPrescriptions, our Patient Advocates handle the entire Avycaz PAP enrollment for a flat $69.95 per month — application, prescriber coordination, manufacturer follow-up, refill management, and annual re-certification — so you never face a gap in Avycaz therapy.

AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Avycaz enrollment — so you never face a gap in your resistant gram-negative infection treatment.

Pharmacy Price Comparison

PHARMACYPRICE (30-DAY) WITH BEST COUPONSYOU SAVE W/ US
Generic colistin (reserve)~$150/doseNephrotoxic reserve alt
Hospital pharmacy~$1,200/doseSave substantially
Community hospital~$1,000/doseSave substantially
Specialty pharmacy~$800/doseSave substantially
340B-eligible institution~$700/doseSave substantially
Zerbaxa (alt gram-neg)~$500/doseAlt beta-lactam combo

*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Avycaz — independent of dosage or retail price.

Our Pricing:

$69.95 Per month

1 Medications

$79.95 Per Month

2 Medications

$89.95 Per Month

3 Medications

$99.95 Per Month

4+ Medications

Why choose us For Your Avycaz Prescription Program?

The Avycaz Patient Assistance Program is free to apply and provides medication at no cost if approved. Our $69.95 per month covers full advocacy: applications, prescriber coordination, hospital administration, refill management, and re-enrollment. Culture-directed therapy is essential — Avycaz is active against KPC-producing Enterobacterales but not against metallo-beta-lactamase producers.

Enroll

Complete a simple eligibility form so our team can determine if you may qualify for Avycaz assistance.

We Advocate

Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.

Receive Medication

Once approved, your Avycaz is delivered through the assistance program while we manage refills and annual renewals.

Discount Coupons vs. Patient Assistance Programs

Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Avycaz:

Limitations of Coupons

  • Prices fluctuate — savings aren’t guaranteed month-to-month

  • Copay accumulators may prevent savings from counting toward your deductible

  • Coupon cards expire and require constant renewal

  • Still $700–$1,200/dose even with the best discount

  • Cannot be used with Medicare, Medicaid, or government insurance

Advantages of PAP Through Us

  • Fixed $69.95/month — never changes regardless of retail price

  • No expiration — continuous access as long as you qualify
  • Medication supplied directly through the assistance program

  • We manage all paperwork, refills, and annual renewals

  • Medicare Part D patients accepted

  • If denied, we explore alternative savings paths on your behalf

DO YOU QUALIFY?

Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Avycaz assistance.

Understanding Avycaz:

Avycaz combines ceftazidime (third-generation cephalosporin) with avibactam (non-beta-lactam beta-lactamase inhibitor) — restoring activity against class A (including KPC), class C, and some class D beta-lactamases. A critical option for KPC-producing carbapenem-resistant Enterobacterales (CRE).


How It Works:

Multidrug-resistant gram-negative bacteria produce beta-lactamases that inactivate beta-lactam antibiotics. KPC (Klebsiella pneumoniae carbapenemase) is a major cause of carbapenem-resistant Enterobacterales (CRE) — historically with limited treatment options. Avibactam is a novel non-beta-lactam beta-lactamase inhibitor that covalently but reversibly inhibits class A (including KPC), class C, and some class D (OXA-48) beta-lactamases. Combined with ceftazidime, it restores activity against KPC producers. It does NOT inhibit metallo-beta-lactamases (MBLs — VIM, IMP, NDM). Emblaveo (aztreonam/avibactam) covers MBL producers.

Form and Use:

Avycaz 2.5 g (ceftazidime 2 g + avibactam 0.5 g) IV every 8 hours over 2 hours. Renal dose adjustment. Duration 5–14 days depending on infection. Culture-directed use — reserve for confirmed or highly suspected resistant gram-negative infection. Metronidazole added for complicated intra-abdominal infections (anaerobic coverage).

Generic Availability:

No generic Avycaz. Other resistant gram-negative antibiotics: Zerbaxa (ceftolozane/tazobactam — Pseudomonas coverage, no KPC), Vabomere (meropenem/vaborbactam — KPC coverage), Recarbrio (imipenem/cilastatin/relebactam — KPC coverage), Fetroja (cefiderocol — broad including MBL producers), Xerava (eravacycline), Emblaveo (aztreonam/avibactam — 2025 FDA-approved for MBL producers), colistin (polymyxin E generic — nephrotoxic reserve), polymyxin B, tigecycline generic, fosfomycin. Culture and sensitivity testing essential.

Warnings:

Serious hypersensitivity reactions including anaphylaxis (contraindicated with beta-lactam allergy), CNS effects (seizures at higher doses in renal impairment), C. difficile-associated diarrhea (severe possible), development of resistance (use for confirmed susceptibility), embryo-fetal considerations. Other: elevated LFTs, cytopenias, positive Coombs test, GI effects, headache, dizziness. Nephrotoxicity less than colistin. Drug interactions minimal. Renal dose adjustment essential.

FAQ (Frequently Asked Questions)

How much does Avycaz cost without insurance?

$700–$1,200 per dose — with typical 3-doses-per-day dosing, costs $2,000–$4,000/day, and full courses $10,000–$40,000+ depending on duration. Specialty pharmacy and Patient Assistance Programs are essential.

Different beta-lactam / beta-lactamase inhibitor combinations with different resistance coverage. Avycaz covers KPC-producing Enterobacterales. Zerbaxa is Pseudomonas-focused (no KPC). Vabomere and Recarbrio cover KPC. Fetroja is broad including MBL producers. Emblaveo (2025) is aztreonam/avibactam for MBL producers. Choice depends on culture/sensitivity results.

Metallo-beta-lactamases (MBLs — VIM, IMP, NDM) are zinc-dependent enzymes with a different mechanism from KPC. Avibactam does not inhibit MBLs. For MBL producers, Fetroja (cefiderocol) or Emblaveo (aztreonam/avibactam — 2025 approval) are options. Colistin remains a reserve.

Essential — Avycaz should be used for confirmed or highly suspected KPC-producing or other susceptible resistant gram-negative infection. Empiric use for undifferentiated infection promotes resistance and wastes expensive therapy. ID consultation is recommended.

Generally well-tolerated. Nausea, vomiting, diarrhea (rule out C. diff), elevated LFTs, cytopenias, hypersensitivity (avoid with beta-lactam allergy), CNS effects at higher doses in renal impairment. Renal dose adjustment is essential to prevent seizures and other CNS effects.

Take Control of Your Medication Costs

Treatment of resistant gram-negative infections should not be delayed by cost. Culture-directed Avycaz can be lifesaving. Our advocacy team is ready — $69.95 per month, or free if we cannot help.

Submit Enrollment Form

Start free by filling out a simple online form.

Receive Welcome Call

Our specialist will contact you for a quick welcome call.

We Manage The Process

Our team handles everything, so you can focus on your health.

Receive Welcome Call

We Manage The Process